image
Healthcare - Medical - Diagnostics & Research - NASDAQ - US
$ 0.71
-10.1 %
$ 21.5 M
Market Cap
-0.65
P/E
1. INTRINSIC VALUE

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.[ Read More ]

The intrinsic value of one STIM stock under the base case scenario is HIDDEN Compared to the current market price of 0.71 USD, Neuronetics, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart STIM

image
FINANCIALS
71.3 M REVENUE
9.42%
-30.6 M OPERATING INCOME
12.98%
-30.2 M NET INCOME
18.76%
-32 M OPERATING CASH FLOW
-4.23%
-1.32 M INVESTING CASH FLOW
-19.64%
22.7 M FINANCING CASH FLOW
10864.73%
18.5 M REVENUE
12.64%
-7.73 M OPERATING INCOME
9.16%
-13.3 M NET INCOME
-35.69%
-5.42 M OPERATING CASH FLOW
-9.02%
14 K INVESTING CASH FLOW
111.76%
-16.4 M FINANCING CASH FLOW
0.00%
Balance Sheet Decomposition Neuronetics, Inc.
image
Current Assets 93.8 M
Cash & Short-Term Investments 60.6 M
Receivables 17.8 M
Other Current Assets 15.4 M
Non-Current Assets 22 M
Long-Term Investments 4.46 M
PP&E 4.78 M
Other Non-Current Assets 12.8 M
Current Liabilities 19.8 M
Accounts Payable 4.75 M
Short-Term Debt 1.69 M
Other Current Liabilities 13.4 M
Non-Current Liabilities 61.8 M
Long-Term Debt 61.6 M
Other Non-Current Liabilities 200 K
EFFICIENCY
Earnings Waterfall Neuronetics, Inc.
image
Revenue 71.3 M
Cost Of Revenue 19.6 M
Gross Profit 51.7 M
Operating Expenses 82.3 M
Operating Income -30.6 M
Other Expenses -365 K
Net Income -30.2 M
RATIOS
72.47% GROSS MARGIN
72.47%
-42.82% OPERATING MARGIN
-42.82%
-42.31% NET MARGIN
-42.31%
-88.30% ROE
-88.30%
-26.06% ROA
-26.06%
-32.37% ROIC
-32.37%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Neuronetics, Inc.
image
Net Income -30.2 M
Depreciation & Amortization 2.01 M
Capital Expenditures -2.37 M
Stock-Based Compensation 7.32 M
Change in Working Capital -14.1 M
Others -3.27 M
Free Cash Flow -34.4 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Neuronetics, Inc.
image
STIM has no price targets from Wall Street.
4. DIVIDEND ANALYSIS
0.00% DIVIDEND YIELD
0 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership Neuronetics, Inc.
image
Sold
0-3 MONTHS
2.39 K USD 2
3-6 MONTHS
92 K USD 1
6-9 MONTHS
497 K USD 3
9-12 MONTHS
237 K USD 3
Bought
146 K USD 2
0-3 MONTHS
217 K USD 2
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
1 month ago
Oct 08, 2024
Sell 1.12 K USD
Furlong Stephen
EVP, CFO and Treasurer
- 1368
0.82 USD
1 month ago
Oct 08, 2024
Sell 1.26 K USD
MACAN WILLIAM ANDREW
EVP, GC, CCO and CS
- 1541
0.82 USD
2 months ago
Sep 12, 2024
Bought 75 K USD
CASCELLA ROBERT
Director
+ 100000
0.75 USD
2 months ago
Sep 05, 2024
Bought 20 K USD
MUIR GLENN P
Director
+ 25000
0.8 USD
2 months ago
Aug 29, 2024
Bought 10.4 K USD
MUIR GLENN P
Director
+ 12224
0.85 USD
2 months ago
Aug 28, 2024
Bought 10.9 K USD
MUIR GLENN P
Director
+ 12776
0.85 USD
2 months ago
Aug 20, 2024
Bought 25 K USD
MUIR GLENN P
Director
+ 25000
1 USD
2 months ago
Aug 19, 2024
Bought 4.56 K USD
CASCELLA ROBERT
Director
+ 4000
1.14 USD
3 months ago
Aug 16, 2024
Bought 37.1 K USD
CASCELLA ROBERT
Director
+ 35000
1.06 USD
3 months ago
Aug 15, 2024
Bought 30.8 K USD
CASCELLA ROBERT
Director
+ 35000
0.88 USD
3 months ago
Aug 14, 2024
Bought 27.6 K USD
CASCELLA ROBERT
Director
+ 35000
0.79 USD
3 months ago
Aug 14, 2024
Bought 18.9 K USD
MUIR GLENN P
Director
+ 25171
0.75 USD
4 months ago
Jul 18, 2024
Sell 45.9 K USD
Sullivan Keith J
President and CEO
- 24162
1.9 USD
4 months ago
Jul 16, 2024
Sell 23.1 K USD
Sullivan Keith J
President and CEO
- 12075
1.91 USD
4 months ago
Jul 17, 2024
Sell 23 K USD
Sullivan Keith J
President and CEO
- 11687
1.97 USD
5 months ago
Jun 06, 2024
Bought 103 K USD
CASCELLA ROBERT
Director
+ 50000
2.051 USD
8 months ago
Feb 28, 2024
Sell 70.7 K USD
MACAN WILLIAM ANDREW
EVP, GC, CCO and CS
- 22377
3.16 USD
8 months ago
Feb 29, 2024
Sell 17.7 K USD
MACAN WILLIAM ANDREW
EVP, GC, CCO and CS
- 6026
2.94 USD
8 months ago
Feb 27, 2024
Sell 70.8 K USD
Furlong Stephen
EVP, CFO and Treasurer
- 21272
3.33 USD
8 months ago
Feb 28, 2024
Sell 12.6 K USD
Furlong Stephen
EVP, CFO and Treasurer
- 3985
3.16 USD
8 months ago
Feb 26, 2024
Sell 67 K USD
Sullivan Keith J
President and CEO
- 20292
3.3 USD
8 months ago
Feb 22, 2024
Sell 67.3 K USD
Sullivan Keith J
President and CEO
- 20851
3.23 USD
8 months ago
Feb 23, 2024
Sell 67 K USD
Sullivan Keith J
President and CEO
- 20750
3.23 USD
8 months ago
Feb 20, 2024
Sell 70.9 K USD
Sullivan Keith J
President and CEO
- 23958
2.96 USD
9 months ago
Feb 14, 2024
Sell 52.8 K USD
MACAN WILLIAM ANDREW
EVP, GC, CCO and CS
- 15621
3.38 USD
9 months ago
Feb 09, 2024
Sell 51.6 K USD
Furlong Stephen
EVP, CFO and Treasurer
- 14710
3.51 USD
9 months ago
Feb 06, 2024
Sell 18.3 K USD
MACAN WILLIAM ANDREW
EVP, GC, CCO and CS
- 5385
3.39 USD
9 months ago
Feb 06, 2024
Sell 19.7 K USD
Furlong Stephen
EVP, CFO and Treasurer
- 5813
3.39 USD
10 months ago
Jan 10, 2024
Sell 30.1 K USD
Sullivan Keith J
President and CEO
- 10013
3.01 USD
10 months ago
Jan 11, 2024
Sell 30.1 K USD
Sullivan Keith J
President and CEO
- 9516
3.16 USD
10 months ago
Dec 19, 2023
Sell 26.1 K USD
MACAN WILLIAM ANDREW
EVP, GC, CCO and CS
- 11664
2.24 USD
10 months ago
Dec 20, 2023
Sell 31.5 K USD
MACAN WILLIAM ANDREW
EVP, GC, CCO and CS
- 11664
2.7 USD
10 months ago
Dec 21, 2023
Sell 29.4 K USD
MACAN WILLIAM ANDREW
EVP, GC, CCO and CS
- 11663
2.52 USD
1 year ago
Oct 06, 2023
Sell 1.7 K USD
MACAN WILLIAM ANDREW
EVP, GC, CCO and CS
- 1469
1.155 USD
1 year ago
Oct 06, 2023
Sell 1.73 K USD
Furlong Stephen
EVP, CFO and Treasurer
- 1499
1.155 USD
1 year ago
Aug 10, 2023
Bought 51.7 K USD
CASCELLA ROBERT
Director
+ 28500
1.813 USD
1 year ago
Jul 21, 2023
Sell 13.4 K USD
Sullivan Keith J
President and CEO
- 6551
2.04 USD
1 year ago
Jul 19, 2023
Sell 13.4 K USD
Sullivan Keith J
President and CEO
- 6479
2.07 USD
1 year ago
Jul 20, 2023
Sell 13.4 K USD
Sullivan Keith J
President and CEO
- 6510
2.06 USD
1 year ago
Jul 11, 2023
Sell 5.63 K USD
MACAN WILLIAM ANDREW
EVP, GC, CCO and CS
- 2645
2.13 USD
1 year ago
May 24, 2023
Sell 38.9 K USD
BAKEWELL JOHN K
Director
- 14400
2.7 USD
1 year ago
Mar 17, 2023
Bought 22.1 K USD
CANNELL CAPITAL LLC
10 percent owner
+ 7644
2.89 USD
1 year ago
Mar 16, 2023
Bought 151 K USD
CANNELL CAPITAL LLC
10 percent owner
+ 52072
2.9 USD
1 year ago
Mar 13, 2023
Bought 405 K USD
CANNELL CAPITAL LLC
10 percent owner
+ 136520
2.97 USD
1 year ago
Mar 07, 2023
Sell 36.5 K USD
CANNELL CAPITAL LLC
10 percent owner
- 7746
4.71 USD
1 year ago
Mar 07, 2023
Sell 58.3 K USD
MACAN WILLIAM ANDREW
EVP, GC, CCO and CS
- 12692
4.59 USD
1 year ago
Mar 07, 2023
Sell 50.9 K USD
Furlong Stephen
EVP, CFO and Treasurer
- 11079
4.59 USD
1 year ago
Feb 15, 2023
Sell 70.6 K USD
MACAN WILLIAM ANDREW
EVP, GC, CCO and CS
- 11974
5.9 USD
1 year ago
Feb 16, 2023
Sell 65.3 K USD
MACAN WILLIAM ANDREW
EVP, GC, CCO and CS
- 11044
5.91 USD
1 year ago
Feb 14, 2023
Sell 69.2 K USD
Furlong Stephen
CFO
- 12403
5.58 USD
1 year ago
Feb 15, 2023
Sell 77.6 K USD
Furlong Stephen
CFO
- 13148
5.9 USD
1 year ago
Feb 13, 2023
Sell 138 K USD
Sullivan Keith J
President and CEO
- 25154
5.49 USD
1 year ago
Feb 14, 2023
Sell 76.2 K USD
Sullivan Keith J
President and CEO
- 13647
5.58 USD
1 year ago
Feb 07, 2023
Sell 30.9 K USD
MACAN WILLIAM ANDREW
SVP and General Counsel
- 5162
5.99 USD
1 year ago
Feb 07, 2023
Sell 33.4 K USD
Furlong Stephen
CFO
- 5584
5.99 USD
1 year ago
Jan 23, 2023
Sell 95.6 K USD
MACAN WILLIAM ANDREW
SVP and General Counsel
- 16046
5.96 USD
1 year ago
Jan 17, 2023
Sell 18.4 K USD
CANNELL CAPITAL LLC
Director
- 2912
6.31 USD
1 year ago
Jan 17, 2023
Sell 98.4 K USD
Furlong Stephen
CFO
- 16050
6.13 USD
1 year ago
Jan 09, 2023
Sell 934 K USD
CANNELL CAPITAL LLC
Director
- 141664
6.59 USD
1 year ago
Jan 10, 2023
Sell 246 K USD
CANNELL CAPITAL LLC
Director
- 36885
6.68 USD
1 year ago
Jan 11, 2023
Sell 57.9 K USD
CANNELL CAPITAL LLC
Director
- 8970
6.45 USD
1 year ago
Jan 12, 2023
Sell 78.1 K USD
CANNELL CAPITAL LLC
Director
- 12397
6.3 USD
1 year ago
Jan 13, 2023
Sell 30.8 K USD
CANNELL CAPITAL LLC
Director
- 4896
6.3 USD
1 year ago
Jan 03, 2023
Sell 109 K USD
CANNELL CAPITAL LLC
Director
- 16440
6.66 USD
1 year ago
Jan 04, 2023
Sell 158 K USD
CANNELL CAPITAL LLC
Director
- 23434
6.73 USD
1 year ago
Jan 05, 2023
Sell 209 K USD
CANNELL CAPITAL LLC
Director
- 33267
6.29 USD
1 year ago
Jan 06, 2023
Sell 171 K USD
CANNELL CAPITAL LLC
Director
- 25937
6.61 USD
1 year ago
Dec 22, 2022
Sell 9.16 K USD
CANNELL CAPITAL LLC
Director
- 1500
6.11 USD
1 year ago
Dec 23, 2022
Sell 39.2 K USD
CANNELL CAPITAL LLC
Director
- 6513
6.02 USD
1 year ago
Dec 27, 2022
Sell 37 K USD
CANNELL CAPITAL LLC
Director
- 6161
6.01 USD
1 year ago
Dec 19, 2022
Sell 82.8 K USD
CANNELL CAPITAL LLC
Director
- 13032
6.35 USD
1 year ago
Dec 20, 2022
Sell 1.15 M USD
CANNELL CAPITAL LLC
Director
- 183198
6.3 USD
1 year ago
Dec 21, 2022
Sell 46.1 K USD
CANNELL CAPITAL LLC
Director
- 7311
6.31 USD
2 years ago
Oct 11, 2022
Sell 4.84 K USD
Furlong Stephen
CFO
- 1630
2.97 USD
2 years ago
Oct 07, 2022
Sell 4.53 K USD
MACAN WILLIAM ANDREW
Sr. VP, GC, CCO and Secretary
- 1547
2.93 USD
2 years ago
Oct 10, 2022
Sell 214 USD
MACAN WILLIAM ANDREW
Sr. VP, GC, CCO and Secretary
- 76
2.82 USD
2 years ago
Jul 25, 2022
Sell 47.2 K USD
Furlong Stephen
CFO
- 13321
3.54 USD
2 years ago
Jul 18, 2022
Sell 236 K USD
Sullivan Keith J
President and CEO
- 63466
3.72 USD
2 years ago
Jul 08, 2022
Sell 9.89 K USD
MACAN WILLIAM ANDREW
Sr. VP, GC, CCO and Secretary
- 2746
3.6 USD
2 years ago
Jun 15, 2022
Bought 3.81 K USD
CANNELL CAPITAL LLC
director:
+ 1130
3.37 USD
2 years ago
Jun 16, 2022
Bought 7.96 K USD
CANNELL CAPITAL LLC
10 percent owner
+ 2576
3.09 USD
2 years ago
Jun 15, 2022
Bought 4.87 K USD
CANNELL CAPITAL LLC
10 percent owner
+ 1364
3.57 USD
2 years ago
Jun 10, 2022
Bought 4.81 K USD
CANNELL CAPITAL LLC
director:
+ 1347
3.57 USD
2 years ago
Jun 13, 2022
Bought 4.74 K USD
CANNELL CAPITAL LLC
10 percent owner
+ 1347
3.52 USD
2 years ago
Jun 10, 2022
Bought 15.1 K USD
CANNELL CAPITAL LLC
10 percent owner
+ 4350
3.46 USD
2 years ago
Jun 01, 2022
Bought 26.9 K USD
CANNELL CAPITAL LLC
director:
+ 10000
2.69 USD
2 years ago
May 26, 2022
Bought 22.9 K USD
CANNELL CAPITAL LLC
director:
+ 8336
2.75 USD
2 years ago
May 27, 2022
Bought 768 USD
CANNELL CAPITAL LLC
10 percent owner
+ 300
2.56 USD
2 years ago
May 26, 2022
Bought 2.22 K USD
CANNELL CAPITAL LLC
10 percent owner
+ 910
2.44 USD
2 years ago
May 25, 2022
Bought 11.4 K USD
CANNELL CAPITAL LLC
10 percent owner
+ 4680
2.44 USD
2 years ago
May 23, 2022
Bought 11.3 K USD
CANNELL CAPITAL LLC
director:
+ 4831
2.34 USD
2 years ago
May 23, 2022
Bought 65.5 K USD
CANNELL CAPITAL LLC
10 percent owner
+ 26612
2.46 USD
2 years ago
May 18, 2022
Bought 37 K USD
CANNELL CAPITAL LLC
director:
+ 15369
2.41 USD
2 years ago
May 19, 2022
Bought 3.26 K USD
CANNELL CAPITAL LLC
10 percent owner
+ 1400
2.33 USD
2 years ago
May 18, 2022
Bought 110 K USD
CANNELL CAPITAL LLC
10 percent owner
+ 47144
2.33 USD
2 years ago
May 10, 2022
Bought 227 K USD
CANNELL CAPITAL LLC
director:
+ 106455
2.13 USD
2 years ago
May 10, 2022
Bought 33.3 K USD
CANNELL CAPITAL LLC
10 percent owner
+ 15191
2.19 USD
2 years ago
May 09, 2022
Bought 16.4 K USD
CANNELL CAPITAL LLC
10 percent owner
+ 7094
2.31 USD
2 years ago
May 06, 2022
Bought 24.2 K USD
CANNELL CAPITAL LLC
10 percent owner
+ 10000
2.42 USD
2 years ago
May 05, 2022
Bought 19.7 K USD
CANNELL CAPITAL LLC
director:
+ 8056
2.44 USD
2 years ago
May 04, 2022
Bought 49.4 K USD
CANNELL CAPITAL LLC
10 percent owner
+ 20000
2.47 USD
2 years ago
May 03, 2022
Bought 38 K USD
CANNELL CAPITAL LLC
10 percent owner
+ 15000
2.53 USD
2 years ago
May 02, 2022
Bought 13.5 K USD
CANNELL CAPITAL LLC
director:
+ 5429
2.48 USD
2 years ago
Apr 26, 2022
Bought 20.4 K USD
CANNELL CAPITAL LLC
10 percent owner
+ 7547
2.7 USD
2 years ago
Apr 22, 2022
Bought 4.75 K USD
CANNELL CAPITAL LLC
director:
+ 1704
2.79 USD
2 years ago
Apr 22, 2022
Bought 4.43 K USD
CANNELL CAPITAL LLC
10 percent owner
+ 1555
2.85 USD
2 years ago
Apr 19, 2022
Bought 595 USD
CANNELL CAPITAL LLC
director:
+ 206
2.89 USD
2 years ago
Apr 11, 2022
Bought 96.2 K USD
CANNELL CAPITAL LLC
director:
+ 33400
2.88 USD
2 years ago
Apr 12, 2022
Bought 224 K USD
CANNELL CAPITAL LLC
10 percent owner
+ 75919
2.95 USD
2 years ago
Apr 11, 2022
Bought 73.8 K USD
CANNELL CAPITAL LLC
10 percent owner
+ 25000
2.95 USD
2 years ago
Apr 06, 2022
Bought 8.94 K USD
CANNELL CAPITAL LLC
director:
+ 2829
3.16 USD
2 years ago
Apr 01, 2022
Bought 730 K USD
CANNELL CAPITAL LLC
10 percent owner
+ 243412
3 USD
2 years ago
Mar 31, 2022
Bought 65.5 K USD
CANNELL CAPITAL LLC
director:
+ 21893
2.99 USD
2 years ago
Mar 25, 2022
Bought 114 K USD
CANNELL CAPITAL LLC
director:
+ 38786
2.94 USD
2 years ago
Mar 25, 2022
Bought 66 K USD
CANNELL CAPITAL LLC
10 percent owner
+ 22062
2.99 USD
2 years ago
Mar 09, 2022
Sell 30 K USD
Furlong Stephen
CFO
- 10029
2.9959 USD
2 years ago
Mar 07, 2022
Sell 32.7 K USD
MACAN WILLIAM ANDREW
Sr. VP, GC, CCO and Secretary
- 11489
2.8488 USD
2 years ago
Mar 07, 2022
Sell 430 USD
MACAN WILLIAM ANDREW
Sr. VP, GC, CCO and Secretary
- 137
3.1385 USD
2 years ago
Feb 08, 2022
Sell 16.2 K USD
Furlong Stephen
CFO
- 5184
3.1248 USD
2 years ago
Feb 09, 2022
Sell 521 USD
Furlong Stephen
CFO
- 166
3.14 USD
2 years ago
Feb 07, 2022
Sell 15.4 K USD
MACAN WILLIAM ANDREW
Sr. VP, GC, CCO and Secretary
- 4716
3.2639 USD
2 years ago
Feb 08, 2022
Sell 49 USD
MACAN WILLIAM ANDREW
Sr. VP, GC, CCO and Secretary
- 15
3.27 USD
2 years ago
Jan 24, 2022
Sell 40.7 K USD
MACAN WILLIAM ANDREW
Sr. VP, GC, CCO and Secretary
- 11562
3.52 USD
2 years ago
Jan 21, 2022
Sell 62.2 K USD
Furlong Stephen
CFO
- 17189
3.62 USD
2 years ago
Jan 24, 2022
Sell 911 USD
Furlong Stephen
CFO
- 268
3.4 USD
2 years ago
Nov 22, 2021
Bought 61.5 K USD
CASCELLA ROBERT
Director
+ 15000
4.0998 USD
3 years ago
Nov 12, 2021
Sell 41.3 K USD
Shook Bruce Joseph
Director
- 7797
5.3 USD
3 years ago
Aug 30, 2021
Bought 101 K USD
CASCELLA ROBERT
Director
+ 15000
6.7233 USD
3 years ago
Jul 28, 2021
Sell 85.8 K USD
Furlong Stephen
CFO
- 6563
13.08 USD
3 years ago
Jul 15, 2021
Sell 685 K USD
Sullivan Keith J
President and CEO
- 50893
13.4579 USD
3 years ago
Jul 16, 2021
Sell 1.27 K USD
Sullivan Keith J
President and CEO
- 93
13.64 USD
3 years ago
Jul 08, 2021
Sell 37.9 K USD
MACAN WILLIAM ANDREW
Sr. VP, GC, CCO and Secretary
- 2591
14.6121 USD
3 years ago
Jun 04, 2021
Sell 37.1 K USD
Furlong Stephen
CFO
- 2473
15.0026 USD
3 years ago
Jun 01, 2021
Sell 87 K USD
CONLEY SHERYL L
Director
- 6200
14.033 USD
3 years ago
May 27, 2021
Sell 203 K USD
Shook Bruce Joseph
Director
- 15200
13.3466 USD
3 years ago
May 28, 2021
Sell 93.7 K USD
CONLEY SHERYL L
Director
- 6800
13.777 USD
3 years ago
May 20, 2021
Sell 194 K USD
Furlong Stephen
CFO
- 12959
15 USD
3 years ago
May 20, 2021
Sell 168 K USD
Furlong Stephen
CFO
- 11121
15.0919 USD
3 years ago
May 21, 2021
Sell 96.2 K USD
Furlong Stephen
CFO
- 6406
15.0126 USD
3 years ago
Mar 09, 2021
Sell 80.9 K USD
Harper Gregory
VP of Prod. Dev. & Operations
- 5524
14.65 USD
3 years ago
Mar 09, 2021
Sell 95.5 K USD
Furlong Stephen
CFO
- 6521
14.64 USD
3 years ago
Mar 09, 2021
Sell 125 K USD
MACAN WILLIAM ANDREW
Sr. VP, GC, CCO and Secretary
- 8537
14.65 USD
3 years ago
Feb 05, 2021
Sell 820 K USD
Sullivan Keith J
President and CEO
- 45632
17.96 USD
3 years ago
Jan 26, 2021
Sell 430 K USD
Sullivan Keith J
President and CEO
- 22829
18.83 USD
3 years ago
Jan 21, 2021
Sell 54.1 K USD
Harper Gregory
VP of Prod. Dev. & Operations
- 2969
18.21 USD
3 years ago
Jan 21, 2021
Sell 138 K USD
Furlong Stephen
CFO
- 7585
18.21 USD
3 years ago
Jan 22, 2021
Sell 270 K USD
MACAN WILLIAM ANDREW
Sr. VP, GC, CCO and Secretary
- 12696
21.28 USD
4 years ago
Mar 13, 2020
Bought 91.2 K USD
Farley Brian E
Director
+ 40000
2.28 USD
4 years ago
Mar 12, 2020
Bought 21.8 K USD
Farley Brian E
Director
+ 10000
2.18 USD
4 years ago
Mar 12, 2020
Bought 11.8 K USD
Guthrie Daniel
Chief Commercial Officer
+ 5000
2.36 USD
4 years ago
Mar 10, 2020
Bought 50 K USD
Furlong Stephen
VP and CFO
+ 25000
2 USD
4 years ago
Mar 10, 2020
Bought 10 K USD
MACAN WILLIAM ANDREW
Sr. VP, GC, CCO and Secretary
+ 5000
2 USD
4 years ago
Dec 16, 2019
Bought 44 K USD
Harper Gregory
VP of R&D, Ops. and Prod. Dev.
+ 10000
4.4 USD
4 years ago
Dec 02, 2019
Bought 10.7 K USD
Guthrie Daniel
Chief Commercial Officer
+ 2500
4.28 USD
4 years ago
Nov 25, 2019
Bought 10.6 K USD
CAMPE STEPHEN M
Director
+ 2500
4.23 USD
4 years ago
Nov 22, 2019
Bought 40.5 K USD
CAMPE STEPHEN M
Director
+ 9500
4.26 USD
5 years ago
Nov 15, 2019
Bought 103 K USD
Furlong Stephen
CFO and Secretary
+ 22959
4.49 USD
5 years ago
Nov 18, 2019
Bought 47 K USD
Farley Brian E
Director
+ 11000
4.27 USD
5 years ago
Nov 14, 2019
Bought 87.4 K USD
Farley Brian E
Director
+ 19000
4.6 USD
5 years ago
Sep 04, 2019
Sell 215 K USD
Thatcher Christopher
President and CEO
- 20000
10.735 USD
5 years ago
May 22, 2019
Sell 53.5 K USD
Guthrie Daniel
Chief Commercial Officer
- 3685
14.53 USD
5 years ago
May 13, 2019
Sell 8.67 K USD
Donato Peter
Vice President and CFO
- 563
15.4 USD
5 years ago
May 14, 2019
Sell 120 K USD
Donato Peter
Vice President and CFO
- 8032
14.9 USD
5 years ago
May 09, 2019
Sell 312 K USD
Donato Peter
Vice President and CFO
- 20469
15.23 USD
5 years ago
May 09, 2019
Sell 29.4 K USD
Donato Peter
Vice President and CFO
- 1878
15.67 USD
5 years ago
May 10, 2019
Sell 10.8 K USD
Donato Peter
Vice President and CFO
- 706
15.3 USD
5 years ago
Apr 08, 2019
Sell 252 K USD
Thatcher Christopher
President and CEO
- 15000
16.82 USD
5 years ago
Mar 08, 2019
Sell 131 K USD
Donato Peter
Vice President and CFO
- 8177
16.01 USD
5 years ago
Mar 07, 2019
Sell 293 K USD
Donato Peter
Vice President and CFO
- 18061
16.21 USD
6 years ago
Jul 02, 2018
Bought 680 K USD
MUIR GLENN P
Director
+ 40000
17 USD
6 years ago
Jul 02, 2018
Bought 113 K USD
JAEGER WILFRED E
Director
+ 6667
17 USD
6 years ago
Jul 02, 2018
Bought 25.5 K USD
Guthrie Daniel
Chief Commercial Officer
+ 1500
17 USD
6 years ago
Jul 02, 2018
Bought 170 K USD
CAMPE STEPHEN M
Director
+ 10000
17 USD
7. News
Neuronetics, Inc. (STIM) Q3 2024 Earnings Call Transcript Neuronetics, Inc. (NASDAQ:STIM ) Q3 2024 Earnings Call November 12, 2024 8:30 AM ET Company Participants Mark Klausner - Investor Relations Keith Sullivan - President and Chief Executive Officer Steve Furlong - Chief Financial Officer Conference Call Participants William Plovanic - Canaccord Genuity James Beers - William Blair Danny Stauder - JMP Operator Good day and thank you for standing by. Welcome to the Neuronetics Third Quarter 2024 Financial and Operating Results Conference Call. seekingalpha.com - 4 days ago
CORRECTION—Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results MALVERN, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- In a release issued earlier today under the same headline by Neuronetics, Inc. (NASDAQ: STIM), please note that in the second paragraph of the "Stockholders Approve Acquisition of Greenbrook TMS" section, it should say that the Company expects to achieve cash flow breakeven by the third quarter of 2025, not the second. The corrected release follows: globenewswire.com - 4 days ago
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) MALVERN, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced the granting of inducement awards of Restricted Stock Units representing a total of 13,500 shares of the Company's common stock (RSUs) to seven new non-executive employees. In accordance with NASDAQ Listing Rule 5635(c)(4), these awards were approved by Neuronetics' Compensation Committee and made as material inducements to their respective employment with the Company. globenewswire.com - 4 days ago
Neuronetics (STIM) Reports Q3 Loss, Lags Revenue Estimates Neuronetics (STIM) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to loss of $0.33 per share a year ago. zacks.com - 4 days ago
Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results MALVERN, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”) a commercial stage medical technology company with a strategic vision of transforming the lives of patients whenever and wherever they need help, with the best neurohealth therapies in the world, today announced its financial and operating results for the third quarter of 2024. globenewswire.com - 5 days ago
Neuronetics to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call MALVERN, Pa., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced that it plans to release third quarter 2024 financial and operating results prior to market open on Tuesday, November 12, 2024. The Company will host a conference call to review its results at 8:30 a.m. Eastern Time the same day. globenewswire.com - 2 weeks ago
NeuroStar® Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with Depression Data selected for oral presentation reinforce previous findings on safety and efficacy Data selected for oral presentation reinforce previous findings on safety and efficacy globenewswire.com - 1 month ago
Neuronetics and Greenbrook TMS Announce Receipt of Interim Order in Respect of Proposed Arrangement and Provide Details of Shareholder Meetings MALVERN, Pa. and TORONTO , Oct. 4, 2024 /PRNewswire/ - Neuronetics, Inc. (NASDAQ: STIM) ("Neuronetics") and Greenbrook TMS Inc. (OTCMKTS: GBNHF) ("Greenbrook") today announced that the Ontario Superior Court of Justice (Commercial List) (the "Court") has granted an interim order (the "Interim Order") in connection with the previously announced statutory plan of arrangement under section 182 of the Business Corporations Act (Ontario) (the "Plan of Arrangement"), pursuant to which, subject to the satisfaction or waiver of all applicable conditions precedent, Neuronetics will acquire all of the issued and outstanding common shares of Greenbrook ("Greenbrook Shares") in an all-stock transaction (the "Arrangement"). prnewswire.com - 1 month ago
Health Care Service Corporation Adds First-Line TMS Coverage for Adolescents Policy update increases access for millions covered by HCSC BlueCross BlueShield policies Policy update increases access for millions covered by HCSC BlueCross BlueShield policies globenewswire.com - 1 month ago
STIM Stock Likely to Gain From Updated TMS Coverage Neuronetics announces that TMS coverage has been updated to reduce access barriers for patients with MDD. In line with this, BCBS and Louisiana Medicaid have expanded their TMS coverage. zacks.com - 1 month ago
Expanded Health Policies Enhance TMS Therapy Access for Adolescents and Adults BlueCross BlueShield of North Carolina and Louisiana Medicaid Increase Coverage for Patients with Depression BlueCross BlueShield of North Carolina and Louisiana Medicaid Increase Coverage for Patients with Depression globenewswire.com - 1 month ago
NeuroStar® Releases Software Upgrades to Elevate Patient Care Upgrades improve communication, streamline data management, and strengthen security Upgrades improve communication, streamline data management, and strengthen security globenewswire.com - 2 months ago
8. Profile Summary

Neuronetics, Inc. STIM

image
COUNTRY US
INDUSTRY Medical - Diagnostics & Research
MARKET CAP $ 21.5 M
Dividend Yield 0.00%
Description Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
Contact 3222 Phoenixville Pike, Malvern, PA, 19355 https://www.neurostar.com
IPO Date June 28, 2018
Employees 203
Officers Mr. Cory S. Anderson Senior Vice President of R&D and Clinical Mr. Stephen J. Furlong M.S. Executive Vice President, Chief Financial Officer & Treasurer Mr. Keith J. Sullivan President, Chief Executive Officer & Director Mr. Rusty Page Senior Vice President of Operations & Quality Ms. Lisa Metzner-Rosas Senior Vice President & Chief Marketing Officer Ms. Sara Grubbs Senior Vice President & Chief Revenue Officer Mr. Rick Grubbs Senior Vice President of National Accounts